This study demonstrates that while the NVBP policy significantly reduced patient drug expenditures and promoted the use of NVBP varieties and nonrestricted antimicrobial agents, it also increased the proportion of special-grade antimicrobials agents, suggesting the need for caution against potential antimicrobial resistance and strengthened supervision of prescription.
Du et al. (Sun,) studied this question.